In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous (SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily),…

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications MADISON, Wis., Dec. 18, 2024 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today an international retrospective…

RIYADH, Saudi Arabia, Dec. 18, 2024 /PRNewswire/ — SAL Logistics Services solidified its position as The National Logistic Champion in Saudi Arabia by announcing a series of strategic partnerships at the Supply Chain and Logistics Conference held on December 15–16, 2024. These strategic…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.